Analyze Diet

Journal of veterinary pharmacology and therapeutics.

Periodical
Pharmacology
Therapeutics
Veterinary Medicine
Drug Therapy
Publisher:
Blackwell Scientific Publications.
Frequency: Bimonthly
Country: England
Language: English
Author(s):
American College of Veterinary Pharmacology & Therapeutics., Association for Veterinary Clinical Pharmacology and Therapeutics., European Association for Veterinary Pharmacology and Toxicology.
Start Year:1978 -
ISSN:
0140-7783 (Print)
1365-2885 (Electronic)
0140-7783 (Linking)
Impact Factor
1.3
2022
NLM ID:7910920
(DNLM):J41230000(s)
(OCoLC):04580359
Coden:JVPTD9
Classification:W1 JO97Q
Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.
Journal of veterinary pharmacology and therapeutics    June 1, 1985   Volume 8, Issue 2 194-201 doi: 10.1111/j.1365-2885.1985.tb00944.x
Orsini JA, Soma LR, Rourke JE, Park M.The pharmacokinetics of amikacin sulfate (AK) were studied in the horse after intravenous (i.v.) and intramuscular (i.m.) administration. Serum (Cs), synovial (Csf) and peritoneal (Cpf) fluid concentrations of the drug were measured. Doses of 4.4, 6.6 and 11.0 mg/kg were given. The concentrations at 15 min following i.v. injection were 30.3 +/- 0.3, 61.2 +/- 6.9 and 122.8 +/- 7.4 micrograms/ml, respectively, for the 4.4, 6.6 and 11.0 mg/kg doses. Mean peak Cs values after the intramuscular injections occurred at 1.0 h post-injection and were 13.3 +/- 1.6, 23.0 +/- 0.6 and 29.8 +/- 3.2 microgra...
Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
Journal of veterinary pharmacology and therapeutics    June 1, 1985   Volume 8, Issue 2 181-189 doi: 10.1111/j.1365-2885.1985.tb00942.x
Woods WE, Chay S, Houston T, Blake JW, Tobin T.Interference or 'masking' in thin layer chromatography occurs when the presence of one drug on a thin layer plate physically obscures or interferes with the detection of another drug. We investigated the ability of phenylbutazone and oxyphenbutazone to mask or interfere with the detection by high performance thin layer chromatography (HPTLC) of basic drugs used illegally in horse racing. Of fifty-five basic drugs called 'positive' since 1981 by laboratories affiliated with the Association of Official Racing Chemists (AORC), forty did not comigrate with phenylbutazone or oxyphenbutazone and cou...
Pharmacokinetic studies of theophylline in horses.
Journal of veterinary pharmacology and therapeutics    March 1, 1985   Volume 8, Issue 1 76-81 doi: 10.1111/j.1365-2885.1985.tb00927.x
Ingvast-Larsson C, Paalzow G, Paalzow L, Ottosson T, Lindholm A, Appelgren LE.The pharmacokinetics of theophylline were determined in Standardbred trotters after single intravenous and oral administration. A bi-exponential equation was fitted to the intravenous data and a tri-exponential equation to the oral data. The biological half-life of theophylline was found to be 14.8 h, the volume of distribution 1.02 l/kg and the total plasma clearance 0.86 ml/kg/min. The oral absorption of the drug was complete (bioavailability 108%) and rapid (absorption half-life 0.4 h).
Pharmacokinetics and bioavailability of theophylline in horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1984   Volume 7, Issue 4 255-263 doi: 10.1111/j.1365-2885.1984.tb00910.x
Errecalde JO, Button C, Baggot JD, Mulders MS.The pharmacokinetics and bioavailability of theophylline in horses were investigated following both intravenous and intragastric administration of aminophylline solutions at doses corresponding to 15 and 10 mg/kg theophylline base. A rapid distributive phase with a half-life of approximately 15-30 min was followed by a slower elimination half-life averaging 15-17 h. The apparent volume of distribution averaged 850-900 ml/kg. Theophylline, administered as aminophylline solution, was both rapidly and completely absorbed from the equine digestive tract. Based on the bioavailability and dispositio...
Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1984   Volume 7, Issue 4 265-276 doi: 10.1111/j.1365-2885.1984.tb00911.x
Chay S, Woods WE, Nugent TE, Weckman T, Houston T, Sprinkle F, Blake JW, Tobin T, Soma LR, Yocum J.Experiments to determine the residual plasma concentrations of phenylbutazone and its metabolites found in horses racing on a 'no-race day medication' or 24-h rule were carried out. One dosing schedule (oral-i.v.) consisted of 8.8 mg/kg (4 g/1000 lbs) orally for 3 days, followed by 4.4 mg/kg (2 g/1000 lbs) intravenously on day 4. A second schedule consisted of 4.4 mg/kg i.v. for 4 days. The experiments were carried out in Thoroughbred and Standardbred horses at pasture, half-bred horses at pasture, and in Thoroughbred horses in training. After administering the i.v. schedule for 4 days to Thor...
Standardization of an experimental disease model of Streptococcus zooepidemicus in the equine.
Journal of veterinary pharmacology and therapeutics    September 1, 1984   Volume 7, Issue 3 183-188 doi: 10.1111/j.1365-2885.1984.tb00898.x
Varma KJ, Powers TE, Powers JD, Spurlock SL.A reproducible experimental disease model in horses using Streptococcus zooepidemicus was developed. An intravenous challenge dose of 1 X 10(10) colony-forming units (CFU), followed 24 h later with another challenge of 1 X 10(8) CFU of Strep. zooepidemicus produced the desired disease model. The disease was characterized by depression, pyrexia, anorexia, abnormal lung sounds, inflammation of joints, moderate to severe lameness, gradual loss of condition and emaciation. The effects of the disease on hematology, serum chemical profile and different protein fractions were studied. The disease sta...
A health index to evaluate clinically a beta-hemolytic streptococcal infectious disease model in the horse.
Journal of veterinary pharmacology and therapeutics    September 1, 1984   Volume 7, Issue 3 213-217 doi: 10.1111/j.1365-2885.1984.tb00902.x
Powers JD, Powers TE, Varma KJ, Gabel AA, Spurlock SL.Quantification of the clinical manifestations of a disease has been a serious problem particularly as related to clinical trials or drug efficacy studies. Historically, this quantification has been limited to categorizing each patient into one of three or four groups, e.g. worse, no improvement, improved. This problem becomes serious when an investigation utilizes an experimentally induced animal disease model. A health index, which quantifies the clinical state of horses which have an experimentally induced beta-hemolytic streptococcal infection, is described. Aspects of experimental design a...
Effects of tryptamine antagonists on the anaphylactic contractions of the bovine pulmonary smooth muscles.
Journal of veterinary pharmacology and therapeutics    June 1, 1984   Volume 7, Issue 2 153-158 doi: 10.1111/j.1365-2885.1984.tb00892.x
Ogunbiyi PO, Eyre P.Calves were sensitized with horse plasma (H.P.), 0.2 ml/kg, i.v., and H.P. (0.2 ml/kg) in Freund's complete adjuvant, s.c. The latter injection was repeated 1 week later and the animals were killed 10 days after the second injection. Spirally cut strips of pulmonary artery and vein and the trachealis muscle from the sensitized calves contracted to 5-hydroxytryptamine (5-HT) and specific antigen (horse plasma). Antigen-induced contractions of the pulmonary smooth muscles were significantly blocked (P less than 0.05) by the 5-HT antagonists, methysergide and ketanserin. The trachea, however, app...
Ivermectin: a review of efficacy and safety.
Journal of veterinary pharmacology and therapeutics    March 1, 1984   Volume 7, Issue 1 1-16 doi: 10.1111/j.1365-2885.1984.tb00872.x
Campbell WC, Benz GW.No abstract available
The effects of combinations of selected antibiotics on the growth of Corynebacterium equi.
Journal of veterinary pharmacology and therapeutics    March 1, 1984   Volume 7, Issue 1 61-64 doi: 10.1111/j.1365-2885.1984.tb00880.x
Prescott JF, Nicholson VM.The minimal inhibitory concentrations of penicillin G, ampicillin, gentamicin, erythromycin and rifampicin were determined for nine strains of Corynebacterium equi. The effect of combinations of any two of these antibiotics on the killing of these strains was determined at antibiotic concentrations achievable in horses using recommended drug dosages (ampicillin 4.0 microgram/ml, gentamicin 1.0 microgram/ml using recommended drug dosages (ampicillin 4.0 microgram/ml, gentamicin 1.0 microgram/ml and erythromycin 0.25 microgram/ml). Penicillin G was used at 4.0 microgram/ml and rifampicin at 0.06...
Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate.
Journal of veterinary pharmacology and therapeutics    March 1, 1984   Volume 7, Issue 1 65-72 doi: 10.1111/j.1365-2885.1984.tb00881.x
Higgins AJ, Lees P.The presence of cyclooxygenase products of arachidonic acid metabolism in carrageenin-induced inflammatory exudate was investigated in ponies using two models. In the first model, an inflammatory response was stimulated by injecting carrageenin into subcutaneously implanted polypropylene tissue cages and exudates were collected at five predetermined times between 3 and 48 h. In the second model, exudates were harvested at 6, 12 and 24 h from carrageenin-impregnated polyester sponges which had also been inserted beneath the skin. Prostaglandin (PG) E2, thromboxane (TX) B2 and the stable breakdo...
Pharmacokinetics of chloramphenicol in the neonatal horse.
Journal of veterinary pharmacology and therapeutics    September 1, 1983   Volume 6, Issue 3 219-227 doi: 10.1111/j.1365-2885.1983.tb00467.x
Brumbaugh GW, Martens RJ, Knight HD, Martin MT.Chloramphenicol sodium succinate was administered as an intravenous bolus (50 mg/kg) to eight foals which weighed 49-57 kg (mean +/- 1 standard deviation = 53.19 +/- 2.66) each, and were 1-9 days (4.5 +/- 2.56) of age. The drug was rapidly distributed and followed first-order elimination. Mean pharmacokinetic values were: zero-time serum concentration (C0) = 36.14 microgram/ml (+/- 14.80); apparent specific volume of distribution (Vd) = 1.614 1/kg (+/- 0.669); and elimination rate constant (K) = 0.7295 h-1 (+/- 0.3066) which corresponds to a biological half-life (t1/2) = 0.95 h. These values d...
A pharmacokinetic study of digoxin in the horse.
Journal of veterinary pharmacology and therapeutics    September 1, 1983   Volume 6, Issue 3 163-172 doi: 10.1111/j.1365-2885.1983.tb00460.x
Brumbaugh GW, Thomas WP, Enos LR, Kaneko JJ.Digoxin was administered orally and intravenously to seven healthy adult mares and geldings in two separate trials. At a dose of 44 microgram digoxin/kg body weight, the oral study was characterized by an absorption phase with a mean (+/- 1 standard deviation) peak serum digoxin concentration of 2.21 ng/ml (+/- 0.45) at a mean of 2.29 h (+/- 1.52) after administration. A second rise in serum digoxin concentration started about 6-8 h after administration and extended to about 20 h after administration. The mean bioavailability (F) was 23.38% (+/- 5.96). At a dose of 22 microgram digoxin/kg body...
Influence of acepromazine maleate on the equine haematocrit.
Journal of veterinary pharmacology and therapeutics    June 1, 1983   Volume 6, Issue 2 121-126 doi: 10.1111/j.1365-2885.1983.tb00388.x
Parry BW, Anderson GA.The effect of acepromazine maleate (ACP) on the equine venous haematocrit and total plasma protein concentration was studied in six clinically normal horses. Total plasma protein concentration was not appreciably influenced by ACP. However, the haematocrit decreased with the duration, but not the degree, of the decrease being dose-related. Mean haematocrit values returned to control levels by 12 h after 0.05 mg ACP/kg body weight and 21 h after 0.15 mg ACP/kg body weight.
Diuretic effect of high-ceiling diuretics in ponies.
Journal of veterinary pharmacology and therapeutics    June 1, 1983   Volume 6, Issue 2 157-158 doi: 10.1111/j.1365-2885.1983.tb00394.x
Frey HH.No abstract available
Pharmacokinetics of phenytoin (diphenylhydantoin) in horses.
Journal of veterinary pharmacology and therapeutics    June 1, 1983   Volume 6, Issue 2 133-140 doi: 10.1111/j.1365-2885.1983.tb00390.x
Kowalczyk DF, Beech J.The pharmacokinetics of the anti-convulsant phenytoin were investigated in clinically healthy horses after oral (p.o.) and intravenous (i.v.) administration. A single dose of phenytoin (8.8 mg/kg body weight) was given i.v. as a bolus to nine horses and one horse received 13.2 mg/kg. A two-compartment open model was used to describe the disposition of phenytoin. Four of the horses that received an i.v. dose (three at 8.8 mg/kg and one at 13.2 mg/kg) were then given the same dose 3 days later by the oral route. Phenytoin achieved a peak concentration in serum within 1-4 h after p.o. administrat...
Pharmacokinetics of erythromycin in foals and in adult horses.
Journal of veterinary pharmacology and therapeutics    March 1, 1983   Volume 6, Issue 1 67-73 doi: 10.1111/j.1365-2885.1983.tb00456.x
Prescott JF, Hoover DJ, Dohoo IR.The pharmacokinetic parameters of erythromycin in foals were determined following intravenous administration of 5.0 mg/kg to animals aged 1, 3, 5 and 7 weeks. The distribution of the drug was described by a two-compartment open model, and no significant differences were observed between coefficients on which the parameters were based. Pharmacokinetic values were also determined for four mares given 5.0 mg/kg intravenously and for six 10-12-week-old foals given 20.0 mg/kg intravenously. The half-life of erythromycin for all groups of animals (foals less than 7 weeks, mares, foals 10-12 weeks) w...
Catecholamines in equine and bovine plasmas.
Journal of veterinary pharmacology and therapeutics    December 1, 1982   Volume 5, Issue 4 279-284 doi: 10.1111/j.1365-2885.1982.tb00443.x
Hardee GE, Wang Lai J, Semrad SD, Trim CM.No abstract available
Xylazine hydrochloride-induced hyperglycemia and hypoinsulinemia in thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    December 1, 1982   Volume 5, Issue 4 241-245 doi: 10.1111/j.1365-2885.1982.tb00439.x
Thurmon JC, Neff-Davis C, Davis LE, Stoker RA, Benson GJ, Lock TF.The effects of intravenous xylazine (1.1 mg/kg) were studied in six thoroughbred horses (five mares and a stallion). Plasma glucose concentration increased to 168% of control at 45 min and decreased to 112% of control at 180 min. Insulin had decreased to 31% of control at 15 min. Thereafter, insulin concentration increased, reaching its highest concentration at 150 min. The mechanism for these changes is not fully understood and further investigation is indicated.
Serum protein binding of furosemide in several species.
Journal of veterinary pharmacology and therapeutics    December 1, 1982   Volume 5, Issue 4 293-294 doi: 10.1111/j.1365-2885.1982.tb00446.x
Neff-Davis CA, Davis LE.No abstract available
Reactivity of equine tracheal smooth muscle to adenosine and some phosphorylated derivatives.
Journal of veterinary pharmacology and therapeutics    September 1, 1982   Volume 5, Issue 3 199-201 doi: 10.1111/j.1365-2885.1982.tb00432.x
Norris AA, Eyre P.No abstract available
‘Detection times’ and ‘clearance times’ for drugs in horses and other animals: a reappraisal.
Journal of veterinary pharmacology and therapeutics    September 1, 1982   Volume 5, Issue 3 195-197 doi: 10.1111/j.1365-2885.1982.tb00431.x
Tobin T, Combie J, Nugent TE.No abstract available
The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
Journal of veterinary pharmacology and therapeutics    September 1, 1982   Volume 5, Issue 3 153-160 doi: 10.1111/j.1365-2885.1982.tb00426.x
Alexander F.The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and anti-diuretic hormone (ADH) on the urinary and faecal excretion of water and electrolytes by ponies was studied. Ethacrynic acid, bumetanide, and frusemide given intravenously, increased urinary sodium excretion, and, excepting frusemide, decreased faecal sodium excretion. Given by stomach tube ethacrynic acid reduced urinary and faecal sodium. Bumetanide, given intravenously, spironolactone, frusemide and ADH increased urinary sodium and all except frusemide intravenously decreased faecal sodium regardless of route of ad...
Performance testing in horses: a review of the role of simple behavioral models in the design of performance experiments.
Journal of veterinary pharmacology and therapeutics    June 1, 1982   Volume 5, Issue 2 105-118 doi: 10.1111/j.1365-2885.1982.tb00505.x
Tobin T, Combie JD.No abstract available
Gentamicin sulfate in the horse: serum, synovial, peritoneal, and urine concentrations after single dose intramuscular administration.
Journal of veterinary pharmacology and therapeutics    June 1, 1982   Volume 5, Issue 2 119-122 doi: 10.1111/j.1365-2885.1982.tb00506.x
Brown MP, Stover SM, Kelly RH, Farver TB.Ten healthy adult mares were given a single intramuscular dose (2.2 mg/kg) of gentamicin sulfate. Over a 48-h period, gentamicin concentrations were measured serially in the serum of all ten mares and in synovial fluid, peritoneal fluid, and urine of six of the mares. The mean peak serum gentamicin concentration was 5.73 micrograms/ml at 1 h. Gentamicin was detected in synovial fluid and peritoneal fluid, with mean peak gentamicin concentrations of 2.41 micrograms/ml and 3.92 micrograms/ml, respectively, observed at 2 h. These concentrations declined in parallel with serum concentrations and w...
Adverse effects of indomethacin in the horse.
Journal of veterinary pharmacology and therapeutics    March 1, 1982   Volume 5, Issue 1 83-86 doi: 10.1111/j.1365-2885.1982.tb00501.x
Roberts MC.No abstract available
The pharmacokinetics, pharmacological responses and behavioral effects of acepromazine in the horse.
Journal of veterinary pharmacology and therapeutics    March 1, 1982   Volume 5, Issue 1 21-31 doi: 10.1111/j.1365-2885.1982.tb00495.x
Ballard S, Shults T, Kownacki AA, Blake JW, Tobin T.After intravenous (i.v.) injection, acepromazine was distributed widely in the horse (Vd = 6.6 litres/kg) and bound extensively (greater than 99%) plasma proteins. Plasma levels of drug declined with an alpha half-life of 4.2 min, while the beta phase or elimination half-life was 184.8 min. At a dosage level of 0.3 mg/kg acepromazine was detectable in the plasma for 8 h post dosing. The whole blood partitioning of acepromazine was 46% in the plasma phase and 54% in the erythrocyte phase. Penile prolapse was clearly evident at doses from 0.01 mg/kg to 0.4 mg/kg i.v., and the duration and extent...
The pharmacokinetics of some aminoglycoside antibiotics in the horse.
Journal of veterinary pharmacology and therapeutics    December 1, 1981   Volume 4, Issue 4 277-284 doi: 10.1111/j.1365-2885.1981.tb00863.x
Baggot JD, Love DN, Rose RJ, Raus J.The disposition kinetics and bioavailability of streptomycin, kanamycin and neomycin were determined following their administration as parenteral preparations to horses. Single doses (10 mg/kg) of each aminoglycoside were given by the intravenous (i.v.) and intramuscular (i.m.) routes and, at a later time, seven intramuscular doses were injected at 12-h intervals. The pharmacokinetic behaviour of the three aminoglycosides was similar, in that a rapid distribution phase was followed by a relatively short half-life. The half-life (mean +/- SD, n = 6) of kanamycin (1.80 +/- 0.17 h) was significan...
The pharmacokinetics of xylazine hydrochloride: an interspecific study.
Journal of veterinary pharmacology and therapeutics    June 1, 1981   Volume 4, Issue 2 87-92 doi: 10.1111/j.1365-2885.1981.tb00715.x
Garcia-Villar R, Toutain PL, Alvinerie M, Ruckebusch Y.The pharmacokinetic disposition of xylazine hydrochloride is described after both intravenous and intramuscular injection of a single dose, in four domestic species: horse, cattle, sheep and dog, by an original high performance liquid chromatographic technique. Remarkably small interspecific differences are reported. After intravenous administration, systemic half-life (t1/2 beta) ranged between 22 min (sheep) and 50 min (horse) while the distribution phase is transient with half-life (t1/2 alpha) ranging from 1.2 min (cattle) to 5.9 min (horse). The peak level of drug concentration in the pla...
The pharmacokinetics of meclofenamic acid in the horse.
Journal of veterinary pharmacology and therapeutics    June 1, 1981   Volume 4, Issue 2 147-156 doi: 10.1111/j.1365-2885.1981.tb00724.x
Snow DH, Baxter P, Whiting B.The pharmacokinetics of meclofenamic acid were studied in Thoroughbred horses and in ponies. After intravenous (i.v.) administration of either 2 mg/kg or 4 mg/kg sodium meclofenamate the elimination half-life was of the order of 0.9 h while the volume of distribution was found to be 0.128 litre/kg. Elimination was in accordance with a one-compartment model. Following oral administration of either meclofenamic acid (4 mg/kg) or sodium meclofenamate (4 mg/kg) a much longer terminal half-life than that calculated for Kel from i.v. data was found. This anomaly indicated that the 'flip-flop' phenom...
1 18 19 20